Vividion Therapeutics
Chanyu Yue is a Senior Scientist with experience in various research roles at companies such as Vividion Therapeutics Inc., Sorrento Therapeutics Inc., and City of Hope Cancer Institute. Chanyu completed a Ph.D. in Biochemistry from Temple University and holds a Bachelor of Science in Biology from Beijing Normal University. Their research has focused on the crosstalk of Ca2+ signaling and type I Interferon induced apoptosis.